Clinical Drug Investigation

, Volume 19, Issue 2, pp 83–91

Tolterodine, an Effective and Well Tolerated Treatment for Urge Incontinence and Other Overactive Bladder Symptoms

  • Michael Chancellor
  • S. Freedman
  • H.D. Mitcheson
  • G. Primus
  • A. Wein
Clinical Use

DOI: 10.2165/00044011-200019020-00001

Cite this article as:
Chancellor, M., Freedman, S., Mitcheson, H. et al. Clin. Drug Investig. (2000) 19: 83. doi:10.2165/00044011-200019020-00001


Objective: This double-blind, multinational study was performed to further evaluate the efficacy of tolterodine, a new bladder-selective antimuscarinic agent, for reducing urge incontinence episodes and other urinary symptoms in patients with overactive bladder.

Patients and Methods: 1022 patients with urge incontinence (≥5 episodes/week) and urinary frequency (≥8 micturitions/24 hours) were randomised to treatment with tolterodine 2mg twice daily (n = 514) or placebo (n = 508). Changes in micturition diary variables were evaluated after 12 weeks’ treatment. Tolerability end-points, and patients’ perceptions of their bladder condition, urgency and treatment benefit, were also determined.

Results: Tolterodine 2mg twice daily reduced urge incontinence episodes by 46% versus baseline, and this decrease was significant compared with the change with placebo (p = 0.0005). Significant decreases from baseline were also observed for micturition frequency (−15%) and pad usage (−36%) compared with placebo (p < 0.01 for both comparisons), while there was a significant increase from baseline in volume voided per micturition (+21%) compared with placebo (p = 0.0001). These changes were meaningful to tolterodine-treated patients; a greater proportion of patients on tolterodine reported less severe urgency and had improvements in their bladder condition than placebo recipients, while 40% perceived ‘much benefit’ from treatment (22% on placebo, p < 0.001). Withdrawals were essentially the same between the two treatment groups. No clinically relevant changes in blood pressure or laboratory parameters were observed.

Conclusions: Tolterodine 2mg twice daily is effective against all the troublesome symptoms of overactive bladder and these effects are meaningful to patients. Tolterodine was well tolerated.

Copyright information

© Adis International Limited 2000

Authors and Affiliations

  • Michael Chancellor
    • 1
  • S. Freedman
    • 2
  • H.D. Mitcheson
    • 3
  • G. Primus
    • 4
  • A. Wein
    • 5
  1. 1.Department of UrologyUniversity of Pittsburgh Medical CenterPittsburghUSA
  2. 2.Las VegasUSA
  3. 3.Bay State Urologists, Inc.BrightonUSA
  4. 4.University Clinic of UrologyGrazAustria
  5. 5.Division of UrologyUniversity of Pennsylvania Health SystemPhiladelphiaUSA

Personalised recommendations